Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 230

1.

Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.

Cristofanilli M, Rosenthal H, Cymring B, Gratch D, Pagano B, Xie B, Sadiq SA.

Exp Neurol. 2014 Aug 8. pii: S0014-4886(14)00248-9. doi: 10.1016/j.expneurol.2014.07.020. [Epub ahead of print]

PMID:
25111532
[PubMed - as supplied by publisher]
2.

Inflammatory Breast Cancer Management in the National Comprehensive Cancer Network: The Disease, Recurrence Pattern, and Outcome.

Matro JM, Li T, Cristofanilli M, Hughes ME, Ottesen RA, Weeks JC, Wong YN.

Clin Breast Cancer. 2014 Jun 23. pii: S1526-8209(14)00112-8. doi: 10.1016/j.clbc.2014.05.005. [Epub ahead of print]

PMID:
25034439
[PubMed - as supplied by publisher]
3.

AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models.

Mu Z, Klinowska T, Dong X, Foster E, Womack C, Fernandez SV, Cristofanilli M.

J Exp Clin Cancer Res. 2014 May 30;33:47. doi: 10.1186/1756-9966-33-47.

PMID:
24886365
[PubMed - in process]
Free PMC Article
4.

Aldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cells.

Woodward WA, Krishnamurthy S, Lodhi A, Xiao L, Gong Y, Cristofanilli M, Buchholz TA, Lucci A.

J Cancer. 2014 Apr 7;5(5):360-7. doi: 10.7150/jca.7885. eCollection 2014.

PMID:
24799954
[PubMed]
Free PMC Article
5.

Survival of women with inflammatory breast cancer: a large population-based study.

Dawood S, Lei X, Dent R, Gupta S, Sirohi B, Cortes J, Cristofanilli M, Buchholz T, Gonzalez-Angulo AM.

Ann Oncol. 2014 Jun;25(6):1143-51. doi: 10.1093/annonc/mdu121. Epub 2014 Mar 24.

PMID:
24669011
[PubMed - in process]
6.

Circulating tumour cells: telling the truth about metastasis.

Cristofanilli M.

Lancet Oncol. 2014 Apr;15(4):365-6. doi: 10.1016/S1470-2045(14)70091-9. Epub 2014 Mar 11. No abstract available.

PMID:
24636207
[PubMed - indexed for MEDLINE]
7.

Circulating giant macrophages as a potential biomarker of solid tumors.

Adams DL, Martin SS, Alpaugh RK, Charpentier M, Tsai S, Bergan RC, Ogden IM, Catalona W, Chumsri S, Tang CM, Cristofanilli M.

Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3514-9. doi: 10.1073/pnas.1320198111. Epub 2014 Feb 18.

PMID:
24550495
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Response of an ERBB2-Mutated Inflammatory Breast Carcinoma to Human Epidermal Growth Factor Receptor 2-Targeted Therapy.

Ali SM, Alpaugh RK, Downing SR, Stephens PJ, Yu JQ, Wu H, Buell JK, Miller VA, Lipson D, Palmer GA, Ross JS, Cristofanilli M.

J Clin Oncol. 2014 Feb 10. [Epub ahead of print] No abstract available.

PMID:
24516025
[PubMed - as supplied by publisher]
9.

The class I HDAC inhibitor Romidepsin targets inflammatory breast cancer tumor emboli and synergizes with paclitaxel to inhibit metastasis.

Robertson FM, Chu K, Boley KM, Ye Z, Liu H, Wright MC, Moraes R, Zhang X, Green TL, Barsky SH, Heise C, Cristofanilli M.

J Exp Ther Oncol. 2013;10(3):219-33.

PMID:
24416998
[PubMed - indexed for MEDLINE]
10.

Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer.

Jeselsohn R, Yelensky R, Buchwalter G, Frampton G, Meric-Bernstam F, Gonzalez-Angulo AM, Ferrer-Lozano J, Perez-Fidalgo JA, Cristofanilli M, Gómez H, Arteaga CL, Giltnane J, Balko JM, Cronin MT, Jarosz M, Sun J, Hawryluk M, Lipson D, Otto G, Ross JS, Dvir A, Soussan-Gutman L, Wolf I, Rubinek T, Gilmore L, Schnitt S, Come SE, Pusztai L, Stephens P, Brown M, Miller VA.

Clin Cancer Res. 2014 Apr 1;20(7):1757-67. doi: 10.1158/1078-0432.CCR-13-2332. Epub 2014 Jan 7.

PMID:
24398047
[PubMed - in process]
11.

Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival.

Bertucci F, Ueno NT, Finetti P, Vermeulen P, Lucci A, Robertson FM, Marsan M, Iwamoto T, Krishnamurthy S, Masuda H, Van Dam P, Woodward WA, Cristofanilli M, Reuben JM, Dirix L, Viens P, Symmans WF, Birnbaum D, Van Laere SJ.

Ann Oncol. 2014 Feb;25(2):358-65. doi: 10.1093/annonc/mdt496. Epub 2013 Dec 2.

PMID:
24299959
[PubMed - in process]
12.

EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells.

Mu Z, Li H, Fernandez SV, Alpaugh KR, Zhang R, Cristofanilli M.

J Exp Clin Cancer Res. 2013 Sep 27;32:70. doi: 10.1186/1756-9966-32-70.

PMID:
24294976
[PubMed - in process]
Free PMC Article
13.

Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinib.

Ali SM, Alpaugh RK, Buell JK, Stephens PJ, Yu JQ, Wu H, Hiemstra CN, Miller VA, Lipson D, Palmer GA, Ross JS, Cristofanilli M.

Clin Breast Cancer. 2014 Feb;14(1):e14-6. doi: 10.1016/j.clbc.2013.09.010. Epub 2013 Sep 27. No abstract available.

PMID:
24201163
[PubMed - in process]
14.

The Third International Inflammatory Breast Cancer Conference.

van Golen KL, Cristofanilli M.

Breast Cancer Res. 2013 Nov 5;15(6):318. doi: 10.1186/bcr3571.

PMID:
24188125
[PubMed - in process]
Free PMC Article
15.

Effects of intraventricular methotrexate administration on Cuprizone-induced demyelination in mice.

Mueller AM, Nassery A, Conlon H, Liu X, Jun E, Yoon BH, Cristofanilli M, Sadiq SA.

Front Mol Neurosci. 2013 Oct 16;6:34. doi: 10.3389/fnmol.2013.00034. eCollection 2013.

PMID:
24137109
[PubMed]
Free PMC Article
16.

Presence of anaplastic lymphoma kinase in inflammatory breast cancer.

Robertson FM, Petricoin Iii EF, Van Laere SJ, Bertucci F, Chu K, Fernandez SV, Mu Z, Alpaugh K, Pei J, Circo R, Wulfkuhle J, Ye Z, Boley KM, Liu H, Moraes R, Zhang X, Demaria R, Barsky SH, Sun G, Cristofanilli M.

Springerplus. 2013 Oct 1;2:497. doi: 10.1186/2193-1801-2-497. eCollection 2013.

PMID:
24102046
[PubMed]
Free PMC Article
17.

A comparison of epidemiology, biology, and prognosis of inflammatory breast cancer in Japanese and US populations.

Natori A, Hayashi N, Soejima K, Deshpande GA, Takahashi O, Cristofanilli M, Ueno NT, Yamauchi H.

Clin Breast Cancer. 2013 Dec;13(6):460-4. doi: 10.1016/j.clbc.2013.08.004. Epub 2013 Sep 29.

PMID:
24084032
[PubMed - indexed for MEDLINE]
18.

Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma.

Andreopoulou E, Vigoda IS, Valero V, Hershman DL, Raptis G, Vahdat LT, Han HS, Wright JJ, Pellegrino CM, Cristofanilli M, Alvarez RH, Fehn K, Fineberg S, Sparano JA.

Breast Cancer Res Treat. 2013 Oct;141(3):429-35. doi: 10.1007/s10549-013-2704-x. Epub 2013 Sep 26.

PMID:
24068539
[PubMed - indexed for MEDLINE]
19.

Cerebrospinal fluid derived from progressive multiple sclerosis patients promotes neuronal and oligodendroglial differentiation of human neural precursor cells in vitro.

Cristofanilli M, Cymring B, Lu A, Rosenthal H, Sadiq SA.

Neuroscience. 2013 Oct 10;250:614-21. doi: 10.1016/j.neuroscience.2013.07.022. Epub 2013 Jul 19.

PMID:
23876320
[PubMed - indexed for MEDLINE]
20.

Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): a multicenter, double-blind, prospective trial.

Jiang ZF, Cristofanilli M, Shao ZM, Tong ZS, Song EW, Wang XJ, Liao N, Hu XC, Liu Y, Wang Y, Zeng L, Zhang M.

Ann Oncol. 2013 Nov;24(11):2766-72. doi: 10.1093/annonc/mdt246. Epub 2013 Jul 14.

PMID:
23857960
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk